Alltrna is the first transfer RNA (tRNA) platform company, and our mission is to unlock tRNA biology and pioneer tRNA therapeutics to regulate the protein universe and resolve disease. Founded at Flagship Labs in 2018, Alltrna has mapped tRNA biology to systematically design tRNA medicines and encode a completely new, unifying approach to treating both rare and common human diseases driven by shared genetic mutations. Alltrna’s platform combines internal expertise and proprietary machine learning tools to unlock the entire tRNA biology space. We have an unprecedented opportunity to advance a single tRNA medicine to restore disrupted protein production, regardless of target, for thousands of diseases with the same underlying genetic mutation.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $159M
Founded date: 2018
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.08.2023 | Series B | $109M | - |
| 09.11.2021 | - | $50M | Flagship P... |
Mentions in press and media 7
| Date | Title | Description |
| 13.10.2023 | Alltrna Announces Series B Raise of $109M | CAMBRIDGE, MA, Alltrna, a company unlocking transfer RNA (tRNA) biology and pioneering tRNA medicines, has raised $109 million in a Series B financing. >> Click here for more funding data on Alltrna >> To export Alltrna fund... |
| 10.08.2023 | USA-based Alltrna raises USD 109 million in Series B | Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA medicines to regulate the protein universe and resolve disease, Alltrna raised USD 109 million in Series B. The round took place on August 9, 2023. The co... |
| 09.08.2023 | Alltrna Raises USD109M Series B Funding | Alltrna, a Cambridge, MA-based company unlocking transfer RNA (tRNA) biology and pioneering tRNA medicines to regulate the protein universe and resolve disease, raised $109m in Series B financing. The round included the company’s founder, F... |
| 15.11.2021 | A New Start-Up Explores Another Genome for Medicines | The biotech incubator Flagship Pioneering launched Moderna to make medicines by engineering messenger-RNA. A mRNA Covid-19 vaccine made Moderna one of the highest valued biotechs. Now, Flagship has unveiled a new firm to make medicines from... |
| - | Meet the 23 biotech startups that are set to take off in the next 12 months, according to top VCs | Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Insider asked 12 venture capitalists which biotech startups would take off in the next 12 months. Here are the 23 companie... |
| - | 10 Boston-area biotechs that VCs say are poised to take off in the next year | Skyline of Boston, Massachusetts. Getty Images. This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Insider asked 12 venture capitalists which biotech startups would take off in the next year... |
| - | Alltrna | “Alltrna is the world’s first tRNA platform company to decipher tRNA biology and pioneer tRNA therapeutics to treat thousands of diseases.” |